Asset 1

Proteogenomics Consortium

Strategic partnership will enable more than a billion peptides to be cataloged to enable the discovery of new protein variants and novel biomarkers leading to therapeutic breakthroughs

The Proteogenomics Consortium will enable genomics customers to more easily add deep, unbiased proteomics data to their discovery, translational, and clinical studies. Through this effort, a capacity for more than one billion peptides to be analyzed and cataloged for discovery of new protein variants and novel biomarkers will be accessible to the market.

Through this multi-year effort, Seer and Sciex will contribute industry-leading proprietary proteomics technologies, and DLS will provide its significant scale and expertise in genomic services and biospecimens, to provide services that support population scale plasma proteogenomic projects.

At Discovery Life Sciences, we believe our employees are at the center of our mission to advance science in an innovative, collaborative, and client-centric environment.

Therefore, we support and empower them in their personal lives and quest for professional growth. We are in search of team members who value diversity and are passionate about making a difference in patients’ lives. We offer competitive compensation and benefits, and hire based on talents, potential and alignment on shared values when it comes towards delivering results while demonstrating collaborative behaviors. We encourage you to apply to become a part of our team!

The Proteogenomics Consortium aims to significantly contribute to expanded understanding of the proteome in an unbiased manner across a variety of cohorts and disease states.

With a phased approach to building a 100,000 sample per- year capacity, the Proteogenomics Consortium will create the capacity, workflows, and expertise to run large scale proteogenomic projects efficiently, quickly and robustly. Through the consortium there is also an opportunity for future collaborations to further pave the way for adoption of proteogenomics via workflow optimization, joint publications and development of novel applications.

To begin a consultation or submit a project inquiry, please contact or fill out the contact form below.

Quick Links


Development and Clinical
Trial Solutions